Bryn Nelson’s no-holds-barred articles on people who can’t swallow normally hit a chord with our readers.
Strep A is among the deadliest pathogens in the world – yet we’ve never prioritised making a vaccine.
Gene therapies could cure a number of illnesses, but often our immune systems get in the way.
To find out why rates vary across the world, scientists are searching for cancer's genomic fingerprints.
Peter Forbes reports on the potential first treatment for this devastating condition.
Joanna Moorhead on the decision she made not to have a mastectomy.
Could a simple anti-inflammatory drug like aspirin really help keep us all healthier?
A special diet for people with epilepsy will often stop or reduce their seizures.
We know that our diet has a huge influence on our health, but is it possible to use food as medicine for a specific disease? Emma Young, who has type 2 diabetes, is sceptical but intrigued.
For some people with swallowing difficulties, hope is a wagging tail.
A group in Seattle opens its doors to Bryn Nelson.
One morning, completely unexpectedly, Samantha Anderson woke to find that she could no longer swallow. Three-and-a-half years and many medical appointments later, she’s finally regaining her ability to eat. Bryn Nelson finds out more.
Meet Dr Jim Olson, the doctor who is revolutionising cancer surgery with ‘Tumour Paint’.
A fundamental problem in chronic fatigue syndrome research is how to know it when you see it.
How can you do medical research on chronic fatigue syndrome when divisions between patients, doctors and researchers are almost as chronic and painful as the disease itself? Virginia Gewin reports on new hopes of reconciliation.
Lingering questions about LASIK’s long-term effects
The lasting lessons of a medical emergency
Some people suffer eye pain so excruciating they feel suicidal, yet ophthalmologists see nothing wrong. Meet the 82-year-old doctor whose radical idea about the real source of this pain is turning heads.
Telling cancer from non-cancer is tough for brain surgeons. Scorpions, Amazon.com and the legacy of a dying girl might change that, writes Alex O'Brien.
Surgeons say they have performed the first transplant using a 'dead' heart. Could this fill the deficit of donor hearts?
The need to mend broken hearts has never been greater. But what if we could simply manufacture a new one? Alex O’Brien studies the legacy of Texan surgeons and artificial hearts.
Treatments for rare diseases challenge a system more used to blockbuster drugs.
More than merely placid test subjects, patients and families are paving – and paying – the way for new drugs.
Drug approvals are evolving - but some say not fast enough.
It’s supposedly getting easier for innovative drugs for rare diseases to reach the market. So why, asks Andy Extance, is hesitancy still proving devastating to desperate families?
Each time we fix up a Mosaic conversation, we ask our subject to bring with them an item.
Alok Jha talks to Harold Varmus, Nobel Prize-winning cancer researcher and current Director of the US National Cancer Institute.